Results 101 to 110 of about 91,737 (262)
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
Case: A 53-year-old man with diabetes mellitus, hypertension, and end-stage renal disease on hemodialysis presented with abdominal pain, bloating, and diarrhea. Abdominal computed tomography demonstrated massive ascites, diffuse peritoneal thickening, and lymphadenopathies.
Kamil, ENLİ +3 more
openaire +1 more source
Genetic testing among patients evaluated for epilepsy surgery
Abstract Objective Genetic testing performed to identify the underlying etiology of epilepsy has become increasingly common and is now being recommended as part of the presurgical evaluation for epilepsy surgery. This study aimed to characterize the types of genetic tests performed in patients evaluated for epilepsy surgery and assess how genetic ...
Anni Saarela +7 more
wiley +1 more source
Propuesta de enfoque diagnóstico y terapéutico de la carcinomatosis peritoneal originada en el colon
Introducción. El cáncer colorrectal corresponde a la cuarta causa de cáncer a nivel mundial, con una incidencia de 17,2 por cada 100.000 habitantes, y en Colombia es de 10,6 por 100.000, con gran mortalidad. El cáncer metastásico a peritoneo se considera
Mauricio García +2 more
doaj
Abstract Objective Epilepsy surgery is an established and effective treatment for children with drug‐resistant epilepsy. Although the majority of patients become seizure‐free postoperatively, 20%–40% experience seizure recurrence. Although repeat surgery can achieve seizure freedom in selected cases, the reasons children with seizure recurrence do not ...
Vincent Zheng +5 more
wiley +1 more source
Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu +3 more
wiley +1 more source

